Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach

Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach

Background. Glioblastoma multiforme (GBM) is a brain tumour with a very high patient mortality rate, with a median survival of 47 weeks. This might be improved by the identification of novel diagnostic, prognostic and predictive therapy-response biomarkers, preferentially through the monitoring of t...

Full description

Bibliographic Details
Main Authors: Zupancic Klemen, Blejec Andrej, Herman Ana, Veber Matija, Verbovsek Urska, Korsic Marjan, Knezevic Miomir, Rozman Primoz, Turnsek Tamara Lah, Gruden Kristina, Motaln Helena
Format: Article
Language:English
Published: Sciendo 2014-09-01
Series:Radiology and Oncology
Subjects:
glioblastoma
proteomics
biomarker
antibody array
plasma
Online Access:https://doi.org/10.2478/raon-2014-0014

Internet

https://doi.org/10.2478/raon-2014-0014

Similar Items